Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]
SEC Accession No. 0000950135-09-003319
Filing Date
2009-04-30
Accepted
2009-04-30 13:22:55
Documents
3
Period of Report
2008-12-31

Document Format Files

Seq Description Document Type Size
1 ALSERES PHARMACEUTICALS, INC. b75176kae10vkza.htm 10-K/A 332025
2 EX-31.1 CERTIFICATION OF THE CHIEF EXECUTIVE OFFICER b75176kaexv31w1.htm EX-31.1 2878
3 EX-31.2 CERTIFICATION OF THE CHIEF FINANCIAL OFFICER b75176kaexv31w2.htm EX-31.2 2953
  Complete submission text file 0000950135-09-003319.txt   339571
Mailing Address 239 SOUTH STREET HOPKINTON MA 01748
Business Address 239 SOUTH STREET HOPKINTON MA 01748 508-497-2360
ALSERES PHARMACEUTICALS INC /DE (Filer) CIK: 0000094784 (see all company filings)

EIN.: 870277826 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K/A | Act: 34 | File No.: 000-06533 | Film No.: 09782370
SIC: 2834 Pharmaceutical Preparations